Elevated serum levels of β-hCG and CA125 were found to be associated with poorer overall survival (OS) and recurrence-free survival (RFS) in patients with urothelial carcinoma undergoing radical cystectomy. This evidence concerns the gene MUC16 and urothelial carcinoma.